Actionable news
All posts from Actionable news
Actionable news in GILD: Gilead Sciences, Inc.,

Gilead Tops Profit Estimates, Raises 2015 Sales Forecast

Gilead Sciences Inc., maker of the hepatitis C drugs Sovaldi and Harvoni, posted third-quarter profit that topped analysts’ estimates and raised its forecast for the year.

Earnings excluding one-time items were $3.22 a share, compared with analysts’ predictions of $2.88, according to an average of estimates compiled by Bloomberg. Revenue increased 37 percent to $8.3 billion, the Foster City, California-based company said Tuesday in a statement. Analysts had predicted $7.86 billion.

The drugmaker also raised its forecast. Product sales for the year will be $30 billion to $31 billion, Gilead said. Previously, the company said 2015 sales would be $29 billion to $30...